Avoidant Personality Disorder Causes, Frequency, Siblings and Mortality - Morbidity

Avoidant Personality Disorder Causes, Frequency, Siblings and Mortality - Morbidity

Causes

  • The exact cause of APD is unknown.
  • The disorder may be related to temperamental factors that are inherited. Specifically, various anxiety disorders in childhood and adolescence have been associated with a temperament characterized by behavioral inhibition, including features of being shy, fearful, and withdrawn in new situations. Components of this temperament have been identified in infants as young as 4 months.
  • Genetic factors have been hypothesized to cause APD and social phobia because both conditions are found more frequently in certain families. The exact mechanism of transmission is unknown, and phenotypic expression of any underlying genetic vulnerability may include other anxiety disorders.
  • Although not specifically studied in cases of APD, traumatic experiences, parental overprotection, poor social skills, and parental anxiety have been found to be related to social anxiety.
  • Retrospective studies of adults with APD report high levels of childhood emotional abuse (61%). Physical abuse, however, may be more closely linked with a diagnosis of another personality disorder or PTSD.
  • A multifactorial model of causation is likely, with several of the above factors exerting variable influence in individual cases.

From an evolutionary point of view, the "fight-or-flight" dichotomy suggests that both hostility & avoidance are naturally occurring responses to fear. Both are thought to be based on anxiety evoked by the presence of a feared stimulus object or situation. However, avoidance can co-vary with fear, vary inversely or vary independently (Rachman & Hodgson, 1974). Therefore, avoidance behavior seems to be more complex than is accountable for by the simple presence of fear or anxiety. What appear to be purposeful hostile reactions to others, for example, may be indicative of highly complex psychological processes.

It is commonly believed that biological factors, including heredity & prenatal maternal factors, set the foundation for personality & personality disorders, while environmental factors shape the form of their expression (Millon & Everly). In the case of avoidant personality disorder, the evidence of major biogenic influences in its etiology & development is speculative & weak (Millon & Everly). However, there is some evidence that a timid temperament in infancy may predispose individuals to developing APD later in life (Kaplan & Sadock, 1991). While shyness appears to indicate underactivity, Kagan believes that this inherited tendency to be shy is actually the result of overstimulation or an excess of incoming information. Timid individuals cannot cope with the excess of information & so withdraw from the situation as a self-protective measure. The inability to cope with this information overload may be due to a low autonomic arousal threshold (Venebles, 1968). The same mechanism may also be responsible for the avoidant's hypervigilence. However, it is generally believed that these biological substrates exist within the avoidant personality as a biological foundation for the emergence of the disorder itself & that full development of APD is likely due to significant environmental influences (Millon & Everly).

    Schizophrenia

    Schizophrenia

    A common and serious mental disorder characterized by loss of contact with reality (psychosis), hallucinations (false perceptions), delusions (false beliefs), abnormal thinking

    Psychotic Disorders

    Psychotic Disorders

    Psychotic disorders are a collection of disorders in which psychosis ...

    Mood disorders

    Mood disorders

    Mood disorders are among the most common diagnoses in psychiatry ...

    Personality Disorders

    Personality Disorders

    The majority of people with a personality disorder never come ...

    Disorders of Childhood and Adolescence

    Disorders of Childhood and Adolescence

    Many disorders seen in adults can occur in children.

    Substance-Related Disorders

    Substance-Related Disorders

    Substance abuse is as common as it is costly to society...

    Cognitive Disorders

    Cognitive Disorders

    The cognitive disorders are delirium, dementia, and amnestic disorders ...

    Anxiety Disorders

    The term anxiety refers to many states in which the sufferer experiences a sense of impending threat ...

    Miscellaneous Disorders

    Miscellaneous Disorders

    Miscellaneous disorders does not refer to any official...

    As the individual gets older there are fewer mandatory (like school) activities that will force them to engage in the world. Their social connectedness can become more and more limited. Their avoidance behaviors can have severe consequences on their social and occupational functioning.

    Frequency

    • In the US: The frequency of APD in children is not known because current psychiatric practice is to avoid labeling children and adolescents with personality disorders and to describe their traits instead. However, in the adult general population, the prevalence is estimated to be 2.1-2.6%.
    • Internationally: The international frequency has not been studied in children.
    • Sex: APD is estimated to be equally common in males and females.

    Diagnosis

    Many individuals experience avoidant personality characteristics at one point or another in their lives. The occasional feelings of self-doubt and fear in new and unfamiliar social or personal relationships is not unusual, nor is it unhealthy, as these situations may cause feelings of inadequacy and social avoidance in even the most self-confident individuals. Avoidant personality traits only emerge as a disorder when they begin to have a long-term, negative impact on the individual, cause functional impairment by significantly altering lifestyle and impacting quality of life, and trigger feelings of distress for the individual.

    The Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV), the standard diagnostic reference for mental health professionals in the United States, states that at least four of the following criteria (or symptoms) must be present in an individual for a diagnosis of avoidant personality disorder:

    • The avoidance of occupational or school activities that involve significant interpersonal contact due to an unreasonable or excessive fear of rejection or criticism.
    • An unwillingness to enter into an interpersonal relationship unless there are assurances of acceptance.
    • Restraint in interpersonal situations because of an unreasonable fear of being ridiculed.
    • Preoccupation with criticism and the possibility of rejection in social situations.
    • Inhibition with others in interpersonal relationships due to feelings of inadequacy.
    • Self-perception of social inadequacy and inferiority to others.
    • Reluctance to participate in new activities or take any personal risks because of a perceived risk of embarrassment.

    Avoidant personality disorder can occur in conjunction with other social phobias, mood and anxiety disorders, and personality disorders. Diagnosis may be complicated by the fact that avoidant personality disorder can either be the cause or result of other mood and anxiety disorders. For example, individuals who suffer from major depressive disorder may begin to withdraw from social situations and experience feelings of worthlessness, symptoms that are also prominent features of avoidant personality disorder. On the other hand, the insecurity and isolation that are symptoms of avoidant personality disorder can naturally trigger feelings of depression.

    Associated features may include hypersensitivity to rejection and criticism.

    Siblings

    The order in which children are born within the family structure has a profound influence on their personality development. That is to say, the parents' expectations and treatment of the oldest child cannot be identical with that of the youngest one and so forth. The conclusion is that each child experiences a different environment within the same family.

    Accompanying the obvious physical distinctions between male and female there is a complex biochemical system which not only distinguishes between the sexes in function, but also creates emotional differences which are further differentiated by the roles and expectations of the society in which they live.

    Because of its gender and the fact that it necessarily views the environment from a different level of maturation, each child in a family will develop a distinctly individual personality.

    Mortality / Morbidity

    The most common syndromes seen with APD include agoraphobia, social phobia (some clinicians see APD as possibly a generalized form of social phobia), generalized anxiety disorder, dysthymia (an emotion of depression), major depressive disorder (the syndrome with all the associated signs and symptoms), hypochondriasis, conversion disorder, dissociative disorder, and schizophrenia.

    • School refusal and poor performance: As many as one third of children who refuse to go to school may have significant social anxiety.
    • Conduct problems and oppositional behavior: Many children with severe social anxiety refuse to participate in social activities and may have behavioral outbursts or panic attacks when placed in a social situation.
    • Poor peer relations: Patients with APD often have few friends and refuse social overtures as children, behavior patterns that persist through adolescence and adulthood.
    • Lack of involvement in social and nonsocial activities: Patients with APD demonstrate lower levels of participation in athletics, extracurricular activities, and hobbies than children with depression or other personality disorders.

    Some Facts on Avoidant Personality Disorder

    Avoidant Personality Disorder (AVPD) is a serious condition characterised by a pattern of withdrawal, self-loathing and heightened sensitivity to criticism. According to DSM IV, people who suffer from AVPD display many of the following traits (Note: These must greatly interfere with the individual's everyday life):

    1. Avoids occupational activities that involve significant interpersonal contact, because of fears of criticism, disapproval, or rejection.
    2. Is unwilling to get involved with people unless certain of being liked.
    3. Shows restraint initiating intimate relationships because of the fear of being ashamed, ridiculed, or rejected due to severe low self-worth.
    4. Is preoccupied with being criticized or rejected in social situations.
    5. Is inhibited in new interpersonal situations because of feelings of inadequacy.
    6. Views self as socially inept, personally unappealing, or inferior to others
    7. Is unusually reluctant to take personal risks or to engage in any new activities because they may prove embarrassing.

    Treatment: Sometimes symptoms can be reduced by taking SSRI antidepressants. Therapy programs typically involve social skills training, cognitive behavioral therapy and group therapy. Getting help with their sensitivity to criticism, their intense fear of rejection, and their social fears is a central part of therapy.

    References

    • Alden L: Short-term structured treatment for avoidant personality disorder. J Consult Clin Psychol 56:756-764, 1989
    • Alden LE, Capreol MJ: Avoidant personality disorder: interpersonal problems as predictors of treatment response. Behavior Therapy 24:357-376, 1993
    • Allgulander C: Paroxetine in social anxiety disorder: a randomized, placebo-controlled study. Acta Psychiatr Scand 100:193-198, 1999
    • Alnaes R, Torgersen S: Personality and personality disorders predict development and relapses of major depression. Acta Psychiatr Scand 95:336-342, 1997
    • Alpert JE, Uebelacker LA, McLean NE, et al: Social phobia, avoidant personality disorder and atypical depression: co-occurrence and clinical implications. Psychol Med 27:627-633, 1997
    • Altamura AC, Pioli R, Vitto M, et al: Venlafaxine in social phobia: a study in selective serotonin reuptake inhibitor non-responders. Int Clin Psychopharmacol 14:239-245, 1999
    • American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 3rd Edition. Washington, DC, American Psychiatric Association, 1980
    • American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 3rd Edition, Revised. Washington, DC, American Psychiatric Association, 1987
    • American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th Edition. Washington, DC, American Psychiatric Association, 1994
    • Baillie AJ, Lampe LA: Avoidant personality disorder: empirical support for DSM-IV revisions. J Personal Disord 12:23-30, 1998
    • Baldwin D, Bobes J, Stein DJ, et al: Paroxetine in social phobia/social anxiety disorder. Br J Psychiatry 175:120-126, 1999
    • Barber JP, Muenz LR: The role of avoidance and obsessiveness in matching patients to cognitive and interpersonal psychotherapy: empirical findings from the Treatment for Depression Collaborative Research Program. J Consult Clin Psychol 64:951-958, 1996
    • Barber JP, Morse JQ, Krakauer ID, et al: Change in obsessive-compulsive and avoidant personality disorders following time-limited supportive-expressive therapy. Psychotherapy 34:133-143, 1997
    • Beck AT, Freeman A: Cognitive Therapy of Personality Disorders. New York, Guilford, 1990
    • Blomhoff S, Huag TT, Humble M, et al: Treatment of generalized social phobia. Paper presented at the annual meeting of the American Psychiatric Association, Washington, DC, May 1999
    • Brooks RB, Baltazar PL, Munjack DJ: Co-occurrence of personality disorders with panic disorder, social phobia, and generalized anxiety disorder: a review of the literature. J Anxiety Disord 3:259-285, 1989
    • Brown EJ, Heimberg RG, Juster HR: Social phobia subtype and avoidant personality disorder: effect on severity of social phobia, impairment, and outcome of cognitive-behavioral treatments. Behavior Therapy 26:467-486, 1995
    • Cappe RF, Alden LE: A comparison of treatment strategies for clients functionally impaired by extreme shyness and social avoidance. J Consult Clin Psychol 54:796-801, 1986
    • Carson R: Self-fulfilling prophecy, maladaptive behavior and psychotherapy, in Handbook of Interpersonal Psychotherapy. Edited by Anchin J, Kiesler D. New York, Pergamon, 1982, pp 64-77
    • Cashdan S: Interactional psychotherapy: using the relationship, in Handbook of Interpersonal Psychotherapy. Edited by Anchin J, Kiesler D. New York, Pergamon, 1982, pp 215-226
    • Chambless DL, Tran GQ, Glass CR: Predictors of response to cognitive-behavioral group therapy for social phobia. J Anxiety Disord 11:221-240, 1997
    • Connor KM, Davidson JRT, Potts NS, et al: Discontinuation of clonazepam in the treatment of social phobia. J Clin Psychopharmacol 18:373-378, 1998
    • Davidson JRT, Ford SM, Smith RD, et al: Long-term treatment of social phobia with clonazepam. J Clin Psychiatry 52 (11, suppl):16-20, 1991
    • Deltito JA, Stam M: Psychopharmacology treatment of avoidant personality disorder: Compr Psychiatry 30:498-504, 1989
    • Emmelkamp PMG, Mersch PP, Vissia E: Social phobia: a comparative evaluation of cognitive and behavioral interventions. Behav Res Ther 23:365-369, 1985
    • Fenichel O: The Psychoanalytical Theory of the Neurosis. New York, WW Norton, 1945
    • Feske U, Chambless DL: Cognitive behavioral versus exposure only treatment for social phobia: a meta-analysis. Behavior Therapy 26:695-720, 1995
    • Feske U, Perry KJ, Chambless DL, et al: Avoidant personality disorder as a predictor for severity and treatment outcome among generalized social phobics. J Personal Disord 10:174-184, 1996
    • Gabbard GO: Cluster C personality disorders, in Psychodynamic Psychiatry in Clinical Practice: The DSM-IV Edition. Washington, DC, American Psychiatric Association, 1994, pp 601-608
    • Greenberg D, Stravynski A: Social phobia. Br J Psychiatry 143:526-527, 1983
    • Heimberg RG: Specific issues in the cognitive-behavioral treatment of social phobia. J Clin Psychiatry 54 (suppl):36-45, 1993
    • Heimberg RG: Social phobia, avoidant personality disorder, and the multiaxial conceptualization of interpersonal anxiety, in Key Trends in Cognitive and Behavioral Therapies. Edited by Salkovskis P. Chichester, UK, Wiley, 1996, pp 103-112
    • Heimberg RG, Dodge GS, Hope DA, et al: Cognitive behavioral treatment for social phobia: comparison to a credible placebo group. Cognitive Therapy and Research 14:1-23, 1990
    • Herbert JD, Hope DA, Bellack AS: Validity of the distinction between generalized social phobia and avoidant personality disorder. J Abnorm Psychol 101:332-339, 1992
    • Holt CS, Heimberg RG, Hope DA: Avoidant personality disorders and the generalized subtype of social phobia. J Abnorm Psychol 101:318-325, 1992
    • Hope DA, Herbert JD, White C: Diagnostic subtype, avoidant personality disorder, and efficacy of cognitive-behavioral group therapy for social phobia. Cognitive Therapy and Research 19:399-417, 1995
    • Horney K: Our Inner Conflicts. New York, WW Norton, 1945
    • Horney K: Neurosis and Human Growth. New York, WW Norton, 1950
    • Jung CG: Psychological types (1936), in Collected Works of C. G. Jung, Vol 6. Edited by McGuire W. Princeton, NJ, Princeton University Press, 1974, pp 550-553
    • Katzelnick DJ, Kobak KA, Greist JH, et al: Sertraline for social phobia: a double-blind, placebo-controlled crossover study. Am J Psychiatry 152:1368-1371, 1995
    • Kelsey JE: Venlafaxine in social phobia. Psychopharmacol Bull 31:767-771, 1995
    • Kessler RC, McGonagle KA, Zheo S, et al: Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch Gen Psychiatry 51:8-19, 1994
    • Kiesler D: Interpersonal theory for personality and psychotherapy, in Handbook of Interpersonal Psychotherapy. Edited by Anchin J, Kiesler D. New York, Pergamon, 1982, pp 3-24
    • Liebowitz MR, Schneier F, Capneas R, et al: Phenelzine vs. atenolol in social phobia, a placebo controlled comparison. Arch Gen Psychiatry 49:290-300, 1992
    • Maier W, Lichterman D, Klinger T, et al: Prevalences of personality disorder (DSM-III-R) in the community. J Personal Disord 6:187-196, 1992
    • Marzillier JS, Lambert C, Kellett J: A controlled evaluation of systematic desensitization and social skills training for socially inadequate psychiatric patients. Behav Res Ther 14:225-238, 1976
    • Mersch PPA, Emmelkamp PMG, Lips C: Social phobia: individual response patterns and the long-term effects of behavioral and cognitive interventions: a follow-up study. Behav Res Ther 29:357-362, 1991
    • Millon T (ed): Modern Psychopathology: A Biosocial Approach to Maladaptive Learning and Functioning. Philadelphia, PA, WB Saunders, 1969, pp 231-233
    • Millon T: Disorders of Personality: DSM-III, Axis II. New York, Wiley, 1981
    • Millon T: Avoidant personality disorder: a brief review of issues and data. J Personal Disord 6:353-362, 1991
    • Millon T: Disorders of Personality: DSM-IV and Beyond. New York, Wiley, 1996
    • Numberg HG, Martin GA, Pollack S: An empirical method to define personality disorder classification using stepwise logistic regression modeling to develop diagnostic criteria and thresholds. Compr Psychiatry 35:409-419, 1994
    • Pande AC, Davidson JR, Jefferson JE, et al: Treatment of social phobia with gabapentin: a placebo-controlled study. J Clin Psychopharmacol 19:341-345, 1999
    • Perugi G, Nassini S, Socci C, et al: Avoidant personality in social phobia and panic-agoraphobia disorder: a comparison. J Affect Disord 54:277-282, 1999
    • Reich J, Noyes R, Yates W: Alprazolam treatment of avoidant personality traits in social phobic patients. J Clin Psychiatry 50:91-95, 1989
    • Rickels K, Schweizer E, Weiss S, et al: Maintenance drug treatment for panic disorder: short and long-term outcome after drug taper. Arch Gen Psychiatry 50:61-68, 1993
    • Schneier FR, Chin SJ, Hollander E, et al: Fluoxetine in social phobia (letter). J Clin Psychopharmacol 12:62-63, 1992
    • Scholing A, Emmelkamp PMG: Prediction of treatment outcomes in social phobia: a cross-validation. Behav Res Ther 377:659-670, 1999
    • Stein MB, Liebowitz MR, Lydiard RB, et al: Paroxetine treatment of generalized social phobia. JAMA 250:708-713, 1998
    • Stein MB, Fyer AJ, Davidson JRT: Fluvoxamine in the treatment of social phobia: a double-blind placebo-controlled study. Am J Psychiatry 156:756-760, 1999
    • Sternbach H: Fluoxetine treatment of social phobia (letter). J Clin Psychopharmacol 10:230, 1990
    • Stravynski A, Marks I, Yule W: Social skills problems in neurotic outpatients: social skills training with and without cognitive modification. Arch Gen Psychiatry 39:1378-1385, 1982
    • Taylor S: Meta-analysis of cognitive-behavioral treatment for social phobia. J Behav Ther Exp Psychiatry 27:1-9, 1996
    • Tran GQ, Chambless DL: Psychopathology of social phobia: effects of subtype and of avoidant personality disorder. J Affect Disord 9:489-501, 1995
    • Turner SM, Biedel DC, Dancu CV, et al: Psychopathology of social phobia and comparison to avoidant personality disorder. J Abnorm Psychol 95:389-394, 1986
    • Turner SM, Beidel DC, Townsley RM: Social phobia: a comparison of specific and generalized subtypes and avoidant personality disorder. J Abnorm Psychol 101:326-331, 1992
    • Turner SM, Beidel DC, Wolff PL, et al: Clinical features affecting treatment outcome in social phobia. Behav Res Ther 34:795-804, 1996
    • Van Ameringen M, Swinson R, Walker JR, et al: A placebo-controlled study of sertraline in generalized social phobia. Paper presented at the 19th National Conference of the Anxiety Disorders Association of America, San Diego, CA, March 25-28, 1999
    • Van Vliet IM, Den Boer J, Westenberg HGM: Psychopharmacological treatment of social phobia: a double-blind placebo controlled study with fluvoxamine. Psychopharmacology (Berl) 115:128-134, 1994
    • Van Vliet IM, Westenberg HGM, van Megan HTGM: Clinical effects of venlafaxine in social phobia. Paper presented at the 11th Congress of the European College of Neuropsychopharmacology (ECNP), Paris, France, October 31-November 4, 1998
    • Versiani M, Nardi AE, Mundim FD, et al: Pharmacotherapy of social phobia: a controlled study with moclobemide and phenelzine. Br J Psychiatry 161:353-360, 1992
    • Widiger TA: Generalized social phobia versus avoidant personality disorder: a commentary on three studies. J Abnorm Psychol 101:340-343, 1992
    • Winston A, Laikin M, Pollack J, et al: Short-term psychotherapy of personality disorders. Am J Psychiatry 151:190-194, 1994
    • World Health Organization: International Classification of Diseases, 10th Revision. Geneva, Switzerland, World Health Organization, 1991
    • Zimmerman M, Coryell WH: Diagnosing personality disorder in the community. Arch Gen Psychiatry 47:527-531, 1990